- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
- Profile
- Financials
OS Therapies (OSTX)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | |
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Operating income | ||
| Operating margin | ||
| Net income | ||
| Net profit margin | ||
| Cash on hand | ||
| Change in cash | ||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 1.88 mm | 1.88 mm | 1.88 mm | 1.88 mm | 1.88 mm | 1.88 mm |
| Cash burn (monthly) | 308.46 k | (no burn) | 2.29 mm | 1.64 mm | 1.57 mm | 1.07 mm |
| Cash used (since last report) | 1.33 mm | n/a | 9.89 mm | 7.08 mm | 6.77 mm | 4.63 mm |
| Cash remaining | 545.90 k | n/a | -8.02 mm | -5.20 mm | -4.89 mm | -2.75 mm |
| Runway (months of cash) | 1.8 | n/a | -3.5 | -3.2 | -3.1 | -2.6 |
| 13F holders | Current |
|---|---|
| Total holders | 5 |
| Opened positions | 4 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 620.62 mm |
| Total shares | 145.00 k |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| CM Management | 110.04 k | $470.99 mm |
| Millennium Management | 29.84 k | $127.70 mm |
| BLK BlackRock | 3.14 k | $13.45 mm |
| MS Morgan Stanley | 1.88 k | $8.05 mm |
| Armstrong Advisory | 100.00 | $428.00 k |
| Proequities | 0.00 | $0.00 |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Oct 25 | Christopher P. Acevedo | Stock options Common Stock | Grant | Acquire A | No | No | 1.8 | 200,000 | 360.00 k | 200,000 |
| 21 Oct 25 | Avril Suzette McKean-Dieser | Stock options Common Stock | Grant | Acquire A | No | No | 1.8 | 140,000 | 252.00 k | 140,000 |
| 21 Oct 25 | Karim Galzahr | Stock options Common Stock | Grant | Acquire A | No | No | 1.8 | 140,000 | 252.00 k | 140,000 |
| 21 Oct 25 | John Ciccio | Stock options Common Stock | Grant | Acquire A | No | No | 1.8 | 140,000 | 252.00 k | 140,000 |
| 21 Oct 25 | Paul A. Romness | Stock options Common Stock | Grant | Acquire A | No | No | 1.8 | 1,950,000 | 3.51 mm | 1,950,000 |